Inventiva (IVA) Convertible Debt (2022 - 2025)

Inventiva's (IVA) quarterly Convertible Debt came in at $1.0 million in Q2 2025, down 39.77% year-on-year from $1.7 million in Q2 2024, and down 46.43% quarter-over-quarter from $1.9 million in Q4 2024.

Inventiva (IVA) Convertible Debt (2022 - 2025) Analysis & Trends

Inventiva's Convertible Debt history runs 4 years deep, the most recent figure standing at $1.0 million for Q2 2025.

  • On a quarterly basis, Convertible Debt fell 39.77% year-over-year to $1.0 million in Q2 2025; TTM through Jun 2025 was $1.0 million, a 39.77% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, up 12.25% from the prior year.
  • Convertible Debt declined to $1.0 million in Q2 2025 per IVA's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $1.9 million in Q4 2024 and bottomed at $1.0 million in Q2 2025.
  • The 4-year median for Convertible Debt is $1.6 million (2023), against an average of $1.5 million.
  • Across the five-year window, Convertible Debt surged 33.23% in 2023 and tumbled 39.77% in 2025, its largest moves.
  • Year by year, Convertible Debt stood at $1.3 million in 2022, then jumped by 33.23% to $1.7 million in 2023, then increased by 12.25% to $1.9 million in 2024, then plunged by 46.43% to $1.0 million in 2025.
  • Per Business Quant, the three latest IVA Convertible Debt figures stand at $1.0 million (Q2 2025), $1.9 million (Q4 2024), and $1.7 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Inventiva 842.48 Mn 842.48 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.01 Mn
Dec 31, 2024 1.88 Mn
Jun 30, 2024 1.67 Mn
Dec 31, 2023 1.68 Mn
Jun 30, 2023 1.48 Mn
Dec 31, 2022 1.26 Mn